Mô tả

Systematic review methodology and study selection for identifying gut microbiome-associated predictors of response to advanced IBD therapies. The review synthesizes evidence on precision medicine approaches for inflammatory bowel disease.

Figure 1

Flowchart

Source Paper

Gut microbiome-associated predictors as biomarkers of response to advanced therapies in inflammatory bowel disease: a systematic review.

Gut microbes (2023)

PMID: 38044504

DOI: 10.1080/19490976.2023.2287073

Cite This Figure

![Figure 1: Systematic review methodology and study selection for identifying gut microbiome-associated predictors of response to advanced IBD therapies. The review synthesizes evidence on precision medicine approaches for inflammatory bowel disease.]()

> Source: Susanna Meade et al. "Gut microbiome-associated predictors as biomarkers of response to advanced thera." *Gut microbes*, 2023. PMID: [38044504](https://pubmed.ncbi.nlm.nih.gov/38044504/)

<figure>
  <img src="" alt="Systematic review methodology and study selection for identifying gut microbiome-associated predictors of response to advanced IBD therapies. The review synthesizes evidence on precision medicine approaches for inflammatory bowel disease." />
  <figcaption>Figure 1. Systematic review methodology and study selection for identifying gut microbiome-associated predictors of response to advanced IBD therapies. The review synthesizes evidence on precision medicine approaches for inflammatory bowel disease.<br>  Source: Susanna Meade et al. "Gut microbiome-associated predictors as biomarkers of response to advanced thera." <em>Gut microbes</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38044504/">38044504</a></figcaption>
</figure>

Bằng chứng liên quan

Butyrate (Sodium/Calcium Butyrate) cho Ulcerative Colitis (UC)

Xếp hạng C · 3 nghiên cứu